Banque Cantonale Vaudoise United Therapeutics Corp Transaction History

Banque Cantonale Vaudoise

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$211.82 - $248.24 $133,658 - $156,639	-631 Reduced 37.85%	1,036 $234,000
Q2 2023 Aug 09, 2023	BUY	$205.19 - $232.99 $281,110 - $319,196	1,370 Added 461.28%	1,667 $368,000
Q4 2022 Feb 10, 2023	SELL	$205.95 - $280.43 $7,620 - $10,375	-37 Reduced 11.08%	297 $83,000
Q3 2022 Oct 17, 2022	BUY	$203.3 - $244.17 $8,945 - $10,743	44 Added 15.17%	334 $70,000
Q2 2022 Aug 02, 2022	SELL	$174.81 - $241.14 $24,123 - $33,277	-138 Reduced 32.24%	290 $68,000
Q3 2021 Oct 29, 2021	SELL	$179.86 - $214.88 $35,252 - $42,116	-196 Reduced 31.41%	428 $79,000
Q1 2021 May 11, 2021	BUY	$153.94 - $174.85 $12,777 - $14,512	83 Added 15.34%	624 $104,000
Q4 2020 Feb 05, 2021	SELL	$101.87 - $151.79 $305 - $455	-3 Reduced 0.55%	541 $82,000
Q3 2020 Oct 30, 2020	SELL	$99.9 - $121.13 $2,397 - $2,907	-24 Reduced 4.23%	544 $54,000
Q2 2020 Jul 22, 2020	BUY	$92.74 - $125.82 $52,676 - $71,465	568 New	568 $69,000

671

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.